“Overwhelmingly preferred” given the rarity of myocarditis COVID-19 vaccine: Report

A Clinical trials Performed by Royal Melbourne Hospital, a 20-year-old man who showed symptoms of myocarditis on a second dose of the COVID-19 mRNA vaccine, the COVID-19 mRNA vaccine is still “all ages” given the low myocarditis. It is overwhelmingly advantageous for gender. ” A group that includes young people. “

A research team led by Joshua Wong of Royal Melbourne Hospital investigated patients who came to the hospital with chest pain, fever, and sweating after the second dose of the Pfizer COVID-19 vaccine.

Twelve hours after receiving the second dose, the patient reportedly began to experience symptoms of headache, night sweats, and chills, despite being well on the first dose 23 days ago, for 48 hours. Later I developed chest pain.

Although the patient had no history of myocarditis, ultrasonography of the heart showed a decrease in left ventricular function commonly associated with myocarditis, suggesting a possible vaccine-induced myocarditis.

Wong and his colleagues also reported elevated troponin levels in patients as a marker of heart damage and inflammation.

The patient was discharged after a complete recovery in 24 hours. So far, no vaccine-induced myocarditis deaths have been reported in Australia. However, he was advised to avoid strenuous activity to allow healing of the myocardium and was scheduled for examination three months later.

Currently in Australia Until January 30, 2022Of the 35.9 million doses given, 1369 cases of myocarditis are suspected. In Australia, the estimated rates of myocarditis are slightly higher, with Moderna and Pfizer doses of 1.7 per 100,000 and 1.4 per 100,000, respectively.

Incidence of Pfizer vaccine-related myocarditis in men aged 12 to 17 years is currently 6.7 and 10.9 per 100,000 on the first and second shots, respectively. The Moderna vaccine has a high incidence in men aged 12 to 17 years, with an incidence of 8.5 and 15.4 per 100,000 on the first and second doses.

However, given the current background incidence of myocarditis (pdfIn the general population of Australians aged 18-34 years, it is estimated that 37 per 100,000 men and 16 per 100,000 females, and the authors say that vaccine-induced myocarditis is “very rare.” It was confirmed that it was a “mild complication”.

by TGA websiteFrom 913,000 vaccinations, no cases of possible myocarditis have been reported for children aged 5 to 11 years until January 30, 2022.

The authors conclude that it is vaccine-related given the rarity, mild symptoms and clinical course of mRNA vaccine-related myocarditis, and the efficacy of the vaccine in reducing SARS-CoV-2 infection. “Still, it’s an overwhelming advantage for all age groups and gender groups.”

93.7% until February 7 (pdf) Two doses in Australia for people over 16 years old 44.83% Of boosters administered to all Australians over the age of 18.

Marina Chan


Marina Chan is based in Melbourne and focuses on Australian news. Contact her at [email protected]

Posted on